Back to Research Home
CVSCVS Health Corp
Health Care · Health Care Services · Large
$93.47−1.07%
As of 23 Oct 2026Mkt cap $124B
Stage 13
AVOID
Fundamentals
30.5/75
Technical
10.8/15
Independent
41.3/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- +9.9%
- 3M
- −12.7%
- 6M
- +19.9%
- 1Y
- +14.0%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 24.8xHist median 17.3x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 10.1x
- FCF yield
- 9.9%
Quality
- ROIC
- 2.9%
- Operating margin
- 2.3%
- FCF margin
- 1.9%
- Current ratio
- 0.8x
Growth
- Revenue growth
- +7.8%Latest FY YoY
- Revenue CAGR
- +8.3%
- EPS CAGR
- −30.7%
- FCF CAGR
- −16.1%
Capital
- Share-count trend
- −0.7%3Y annualised
- Net debt
- $55.3B5.2x OCF
Annual trend
- CAGR 2021–2025
- +8.3%
- Latest · 2025
- $402B
- YoY
- +7.8%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-04
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded